Invitae is a leader in advanced medical genetics.
UnitedHealthcare created a "Preferred Laboratory Network (PLN)".Invitae has been selected as one of the seven lab companies.
LMT 1- 18.9$ (25 % of the planned investment amount)
LMT 2- 17.34$ (55 % of the planned investment amount)
LMT 3- 14.79$ (20 % of the planned investment...
Looks like NVTA is continuing its uptrend. Currently looks like the possibility for a slight pull back at resistance accompanied by divergence in MACD and pricing. Once pullback is complete, opportunity for completing 5 waves is still there.
He may not be to the liking of all, but when Andrew left makes a trade public it moves the stock, that is exactly what happened to NYSE:NVTA in today's trading.
"I am long a lot," Left told TheStreet, adding that he thinks NVTA could hit $100 a share two years from now. He also said it's very possible that the company will be acquired before reaching that level....
The market God's have spoken in my eyes nvta is destined to break out to the $16-20 range. Fundamentals support this plan along with general beta weight. Technicals giving a potential green light possibly next week?